A Prospective, Open Label, One-arm, 4-weeks Study Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease Phase 1 Study in Dry Eye Patients
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 30 Aug 2018 Status changed from recruiting to completed.
- 18 Sep 2017 Status changed from not yet recruiting to recruiting.
- 18 Jul 2017 New trial record